BCPC SVP granted stock and options

BCPC senior executive Graham George reported equity awards from the company.

Rhea-AI Filing Summary

BCPC senior executive Graham George reported equity awards from the company. As SVP and Chief R&D Officer, he received a grant of 700 shares of common stock at a price of $0, increasing his directly held common stock to 3,200 shares, plus 20 shares held indirectly through a 401(k) plan.

The filing also shows a stock option grant for 2,600 shares of common stock with an exercise price of $178.68 per share, expiring on 02/11/2036. The restricted stock vests over three years (25%, 25%, 50%), while the options vest 20% in year one, 40% in year two, and 40% in year three.

Insider Trade Summary

Grant/Award: 3,300 shares

Grant/Award 3 txns

Insider Graham George

Role SVP and Chief R&D Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	2,600	$0.00	$0.00
Grant/Award	Common Stock	700	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option — 2,600 contracts (Direct); Common Stock — 3,200 shares (Direct); Common Stock — 20 shares (Indirect, 401(k) Plan)

Footnotes (2)

1. F1. Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
2. F2. Options vest 20% Year 1, 40% Year 2, and 40% Year 3.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did BCPC executive Graham George report on this Form 4?

Graham George reported equity compensation grants, not open-market trades. He acquired 700 shares of common stock at $0 and a stock option for 2,600 shares at $178.68 per share, reflecting routine stock and option awards as part of his compensation.

How many BCPC shares does Graham George own after the reported transactions?

After the reported grants, Graham George directly owns 3,200 shares of BCPC common stock and indirectly holds 20 shares through a 401(k) plan. These figures reflect his beneficial ownership following the restricted stock award and the separate stock option grant disclosed in the filing.

What are the key terms of Graham George’s BCPC stock option grant?

The stock option grant covers 2,600 BCPC shares at an exercise price of $178.68 per share and expires on 02/11/2036. The options vest over three years, with 20% vesting in year one, 40% in year two, and 40% in year three.

How does the BCPC restricted stock granted to Graham George vest?

The 700 restricted BCPC shares vest over three years. According to the filing, 25% vest on the first anniversary of the grant date, another 25% on the second anniversary, and the remaining 50% on the third anniversary, subject to a Restricted Stock Grant Agreement.

Is Graham George’s BCPC Form 4 transaction a stock purchase or compensation grant?

The Form 4 reflects compensation grants rather than market purchases. Both the 700 shares of common stock and the 2,600-share stock option were reported with a price of $0 for the acquisition, indicating awards granted as part of his executive compensation package.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 06:40 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Graham George

(Last) (First) (Middle)

C/O BALCHEM CORPORATION

5 PARAGON DRIVE

(Street)

MONTVALE NJ 07645

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BALCHEM CORP [ BCPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and Chief R&D Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		A		700(1)	A	$0	3,200	D
Common Stock								20	I	401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$178.68	02/11/2026		A		2,600		(2)	02/11/2036	Common Stock	2,600	$0	2,600	D

Explanation of Responses:

1. Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

2. Options vest 20% Year 1, 40% Year 2, and 40% Year 3.

	/s/ Travis Larsen, Attorney in Fact for George Graham	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.